We’re back. After a short hiatus, the team that brought you the best global medtech coverage in publications like IN VIVO, START-UP and MEDTECH INSIGHT, and the IN3 investor conferences, has reunited to form a new information provider, Innovation In Medtech, focused exclusively on the under-served and rapidly changing medtech market.
As we look back on the 40-plus years we’ve spent covering this industry, the transformation has truly been dramatic on all fronts. We are seeing technology advances that people barely imagined, benefitting more patients than ever throughout the world as medtech indeed has become a global industry. With those advances have come increased challenges, be it the changing financing landscape that impacts early-stage companies seeking funding, or the shifting healthcare economic climate that is altering the model of who decides which products to buy and what they will pay for them. This rapid evolution makes it more critical than ever that our industry have a go-to source for reliable, in-depth news and analysis to help decision-makers understand today’s device space, and prepare for tomorrow. That is our goal: to provide superior content backed by unparalleled industry experience.
Our flagship product is a new twice-monthly publication, THE MEDTECH STRATEGIST (MTS), that will provide broad coverage of the most important topics and trends in medical devices today, filling a void created by recent changes in the information landscape. THE MEDTECH STRATEGIST will bring together in one publication a level of coverage of the device industry broader and deeper than any other source. Brought to you by the most experienced editorial team in the business – with more than 100 years of collective experience covering the industry – MTS will feature interviews with industry leaders, stories on leading companies, profiles of ground-breaking start-ups and analyses of dynamic clinical markets and technology trends, all in an effort to not just explain what is going on in the device space today, but why these events are occurring and what they may lead to in the future on a worldwide scale.
You can look forward to a publication covering global medtech innovation in all of its various forms: clinical, technological, business model, marketplace, and financing innovation. Our new publication will offer a combination of the in-depth feature articles for which we are known, along with shorter industry pieces, profiles of emerging companies and overviews of critical clinical markets, providing insight and analysis currently missing in the medtech industry. And we look forward to hearing from you about the topics and issues you’d like to see covered. THE MEDTECH STRATEGIST will offer the best of the kind of writing we used to do for IN VIVO, START-UP, and MEDTECH INSIGHT, in a single, robust publication dedicated exclusively to the medical device industry.
Through THE MEDTECH STRATEGIST and upcoming conferences, we look forward to re-connecting with our many friends in the industry, while also introducing ourselves to a new group of readers by continuing to deliver the superior level of coverage and analysis that the medtech industry needs and deserves. It’s good to be back.